Invention Grant
US08268562B2 Biomarkers for predicting response of esophageal cancer patient to chemoradiotherapy
有权
用于预测食管癌患者对放化疗的反应的生物标志物
- Patent Title: Biomarkers for predicting response of esophageal cancer patient to chemoradiotherapy
- Patent Title (中): 用于预测食管癌患者对放化疗的反应的生物标志物
-
Application No.: US12582357Application Date: 2009-10-20
-
Publication No.: US08268562B2Publication Date: 2012-09-18
- Inventor: Pei-Chun Chen , Yen-Ching Chen , Liang-Chuan Lai , Mong-Hsun Tsai , Shin-Kuang Chen , Pei-Wen Yang , Jang-Ming Lee , Eric Y. Chuang , Chuhsing K. Hsiao
- Applicant: Pei-Chun Chen , Yen-Ching Chen , Liang-Chuan Lai , Mong-Hsun Tsai , Shin-Kuang Chen , Pei-Wen Yang , Jang-Ming Lee , Eric Y. Chuang , Chuhsing K. Hsiao
- Applicant Address: TW Taipei
- Assignee: National Taiwan University
- Current Assignee: National Taiwan University
- Current Assignee Address: TW Taipei
- Agency: WPAT, P.C.
- Agent Anthony King
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C07H21/04 ; C12P19/34
Abstract:
The present invention relates to novel genetic markers associated with response of a patient with esophageal cancer (ECa) to chemoradiation therapy, and particularly to methods and kits for predicting an ECa patient's response to chemoradiation therapy by genotyping of the markers.
Public/Granted literature
- US20110091871A1 BIOMARKERS FOR PREDICTING RESPONSE OF ESOPHAGEAL CANCER PATIENT TO CHEMORADIOTHERAPY Public/Granted day:2011-04-21
Information query
